PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 64 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,221,022 | -10.7% | 2,266,350 | -5.3% | 0.01% | -16.7% |
| Q4 2022 | $2,487,718 | -11.4% | 2,392,036 | -2.0% | 0.01% | 0.0% |
| Q3 2022 | $2,807,000 | -40.7% | 2,441,195 | -3.5% | 0.01% | -40.0% |
| Q2 2022 | $4,730,000 | -39.9% | 2,529,679 | -2.6% | 0.01% | -33.3% |
| Q1 2022 | $7,871,000 | -5.5% | 2,597,466 | +17.9% | 0.02% | 0.0% |
| Q4 2021 | $8,330,000 | +634.6% | 2,203,777 | +904.3% | 0.02% | +200.0% |
| Q3 2021 | $1,134,000 | +1353.8% | 219,428 | +975.2% | 0.01% | – |
| Q2 2021 | $78,000 | -54.4% | 20,409 | -56.9% | 0.00% | -100.0% |
| Q4 2019 | $171,000 | -90.5% | 47,342 | -85.3% | 0.00% | -87.5% |
| Q3 2018 | $1,804,000 | +1428.8% | 322,156 | +1279.8% | 0.01% | +300.0% |
| Q2 2018 | $118,000 | – | 23,348 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
| Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
| CM Management, LLC | 649,400 | $193,521 | 0.20% |
| BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
| WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
| NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
| TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
| Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |